Evidence map›Paper›PMID 22702471›Full record

ArticleXenotransplantation

Complete absence of the αGal xenoantigen and isoglobotrihexosylceramide in α1,3galactosyltransferase knock-out pigs.

Gisella L Puga Yung, Yunsen Li, Lubor Borsig, Anne-Laure Millard, Maria B Karpova, Dapeng Zhou, Jörg D Seebach

Open access · greenAbstract read
In one paragraph

Article in Xenotransplantation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. The Journal of biological chemistry · 2017
    Article
  8. Article
  9. The Role of NK Cells in Pig-to-Human Xenotransplantation.Journal of immunology research · 2017
    Review
  10. Blood Groups in Infection and Host Susceptibility.Clinical microbiology reviews · 2015
    Review
  11. Article
  12. Article
  13. Reduced binding of human antibodies to cells from GGTA1/CMAH KO pigs.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2014
    Article
  14. Immunological challenges and therapies in xenotransplantation.Cold Spring Harbor perspectives in medicine · 2014
    Review
  15. Lung transplantation.F1000prime reports · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Gisella L Puga YungDivision of Clinical Immunology and Allergology, Department of Internal Medicine, University Hospital and Medical Faculty Geneva, Geneva, Switzerland.
Yunsen Li
Lubor Borsig
Anne-Laure Millard
Maria B Karpova
Dapeng Zhou
Jörg D Seebach
The University of Texas MD Anderson Cancer Center · USUniversity Hospital of Geneva · CHUniversity Hospital of Zurich · CHUniversity of Zurich · CH

Funding

Virology CoreP30AI036211 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI BUTEL, JANET S · 1994 to 2015
$21.7M
Endogenous glycosphingolipid antigens for NKT cellsR01AI079232 · NIAID · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ZHOU, DAPENG · 2009 to 2013
$1.9M
Alpha-galactosycleramide as a mucosal adjuvant for HIV antigensR21AI078898 · NIAID · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SASTRY, JAGANNADHA K · 2009 to 2010
$424k
NIAID NIH HHS AI078898NIAID NIH HHS AI079232NIAID NIH HHS P30 AI036211NIAID NIH HHS P30-AI36211NIAID NIH HHS R01 AI079232NIAID NIH HHS R21 AI078898
6 · The paper itself

Abstract

backgroundAnti-Galα1,3Galβ-R natural antibodies are responsible for hyperacute rejection in pig-to-primate xenotransplantation. Although the generation of pigs lacking the α1,3galactosyltransferase (GalT) has overcome hyperacute rejection, antibody-mediated rejection is still a problem. It is possible that other enzymes synthesize antigens similar to Galα1,3Gal epitopes that are recognized by xenoreactive antibodies. The glycosphingolipid isoglobotrihexosylceramide (iGb₃) represents such a candidate expressing an alternative Galα1,3Gal epitope. The present work determined whether the terminal Galα1,3Gal disaccharide is completely absent in Immerge pigs lacking the GalT using several different highly sensitive methods.

methodsThe expression of Galα1,3Gal was evaluated using a panel of antibodies and lectins by flow cytometry and fluorescent microscopy; GalT activity was detected by an enzymatic assay; and ion trap mass spectroscopy of neutral cellular membranes extracted from aortic endothelial was used for the detection of sugar structures. Finally, the presence of iGb₃ synthase mRNA was tested by RT-PCR in pig thymus, spleen, lymph node, kidney, lung, and liver tissue samples.

resultsAortic endothelial cells derived from GalT knockout pigs expressed neither Galα1,3Gal nor iGb₃ on their surface, and GalT enzymatic activity was also absent. Lectin staining showed an increase in the blood group H-type sugar structures present in GalT knockout cells as compared to wild-type pig aortic endothelial cells (PAEC). Mass spectroscopic analysis did not reveal Galα1,3Gal in membranes of GalT knockout PAEC; iGb₃ was also totally absent, whereas a fucosylated form of iGb₃ was detected at low levels in both pig aortic endothelial cell extracts. Isoglobotrihexosylceramide 3 synthase mRNA was expressed in all pig tissues tested whether derived from wild-type or GalT knockout animals.

conclusionsThese results confirm unequivocally the absence of terminal Galα1,3Gal disaccharides in GalT knockout endothelial cells. Future work will have to focus on other mechanisms responsible for xenograft rejection, in particular non-Galα1,3Gal antibodies and cellular responses.

Indexed as

Acute DiseaseAnimalsAntigens, HeterophileAortaDisaccharidesEndothelial CellsFemaleGalactosyltransferasesGene Knockdown TechniquesGlobosidesGraft RejectionPrimatesRNA, MessengerSwineSwine, MiniatureTransplantation, HeterologousAntigens, HeterophileDisaccharidesgalactosyl-(1-3)galactoseGalactosyltransferasesGlobosidesisoglobotriaosylceramideN-acetyllactosaminide alpha-1,3-galactosyltransferaseRNA, Messenger

Identifiers

PMID22702471
PMCPMC3614413
OpenAlexW2153014354

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.